1. Evenity, a monthly injection, is approved to treat osteoporosis is postmenopausal women at high risk of bone fracture.
2. Dovato is a two-drug, fixed-dose complete regimen for HIV patients who have not received antiretroviral treatment.
3. The FDA expanded indication of Ibrance, a metastatic breast cancer treatment, to include male patients.
4. The FDA expanded the label for Keytruda, a cancer immunotherapy drug, as monotherapy for the first-line treatment of patients with stage 3 non-small cell lung cancer who are not able to receive surgical resection of chemoradiation.
More articles on supply chain:
FDA braces for medical device shortages: 9 things to know
Reports of breast implant ‘illness’ spur FDA safety review
5 supply chain technologies to watch
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
